Trial Profile

Placebo-Controlled Proof of Concept Study to Investigate ANB020 Activity in Adult Patients With Peanut Allergy

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 31 Jul 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Etokimab (Primary)
Indications Peanut hypersensitivity
Focus Adverse reactions; Proof of concept
Sponsors AnaptysBio

Most Recent Events

25 Jun 2018 Status changed from active, no longer recruiting to completed.
26 Mar 2018 According to an AnaptysBio media release, Stephen Tilles is an investigator of this trial. The company plans to report detailed data from this trial at a future medical conference following study completion.
26 Mar 2018 Interim results published in an AnaptysBio Media Release

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com